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The JeffCare Preceptor Model for Asthma:
A Primary Care Physician Tutorial Training Model
JEFFREY L. LENOW, M.D., J.D.,1,2 ROBERT BALES, M.D., M.P.H.,3
and STANTON N. SMULLENS, M.D.4,5,6

ABSTRACT
The societal and economic impact of asthma is a well-documented phenomenon in this country. Despite improved knowledge and techniques of care, there have been signs of worsening morbidity/mortality and a seeming disconnect between physician and patients as regards
communication of care strategies. In an attempt to fashion innovative educational strategies
to enhance primary care physician (PCP) and caregiver efficiencies in improving patient outcomes (clinical and financial), the “Preceptor” model of one-to-one PCP/asthma specialist has
been developed. Review of utilization and prescribing data demonstrates a clear pattern of
statistically significant cost improvement in the aggregate care setting, as well as improved
appropriateness of use of proper asthma medications. Use of the “Preceptor” model of PCP
learning is an effective and unique way to enhance both caregiver knowledge and improved
care efficiency in asthma management.

termed the “era of accountability” in the health
care delivery industry, where evidence-based
problem solving strategies are fast becoming
determinants of success and failure for practitioners and health care systems.4 The emergence of the disease management discipline has
offered opportunities to design innovative new
learning methodologies for caregivers on the
“front lines” of medicine, the primary care
physicians (PCPs), to address identified gaps
in the physician–patient educational nexus.5
Creating such models for PCPs is challenging
given the lack of time today’s practitioners
have available for extraneous learning activities. Yet, reliance on traditional models of continuing learning may be insufficient for mod-

INTRODUCTION

C

will derive from a
balanced perspective of both quality and
cost. The industry of disease management
offers flexible approaches that can enable innovative and low-cost strategies to help operationalize improvement. Certainly, the employer industry, which pays a significant
portion of health premiums, has begun to make
its voice heard by way of the Leapfrog initiative,1 and the industry as a whole has been profoundly influenced to focus on quality improvement initiatives to enhance patient safety
and reduce medication errors. 2,3 We are aggressively entering what can properly be
LINICAL IMPROVEMENT
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ern learners, and the movement toward interactive and case-based models of continuing education is being demonstrated to have a more
effective impact.6
Jefferson Medical College of Thomas Jefferson University in Philadelphia, PA has thus
partnered with its physician hospital organization, JeffCare, Inc., to define such a new model
of learning for its primary care network utilizing what we call the “Preceptorship” program.
(JeffCare, Inc., is a wholly owned subsidiary of
Thomas Jefferson University Hospital, responsible for network development and managed
care contracting.) The primary focus of this program has been on asthma education and management. In Philadelphia, it has long been observed that there is a significant prevalence of
asthma, especially in the inner city metropolitan service area of Thomas Jefferson University
Hospital, with a disproportionate rate of deaths
from this disease.7 Lang and Polansky8 noted
that the rates of death from asthma have increased in Philadelphia, whereas concentrations of major air pollutants have declined
within particular problem areas affecting the
minority, poor, and African American populations. Clearly, improving educational approaches in asthma care for the front-line PCP
caregivers is a compelling need.
An additional reason to pursue more effective modalities of provider education comes
with the recognition that the cost of care from
chronic asthma illness continues to rise.9 In
2000, the then Surgeon General, David Satcher,
M.D., revealed data demonstrating a dramatic
rise in cases of asthma over the last 15 years reflecting in the increasing drain on the U.S. economy: from $4.5 billion in 1985 to $10.7 billion
in 1994.10 Estimates, of course, will vary based
on the estimating methodology used. In a Centers for Disease Control and Prevention publication in the year 2000, direct and indirect costs
associated with asthma during 1998 were an
estimated $12.7 billion.11 Smith et al12 noted
asthma cost breakdown as follows: office visits, 12%; hospital outpatient visits, 11%; emergency room, 6.8%; hospitalization, 54.4%.
Clearly, given the societal and economic significance of this disease process, new models
of caregiver education are warranted. Of special concern is the trend toward increasing
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prevalence of asthma in our market area of
metropolitan Philadelphia, which includes a
large inner city population. Currently, nearly
one out of 13 persons in southeastern Pennsylvania (7.4%, or 274,300 persons) report having asthma, representing 185,000 adults (6.6%)
and 89,000 children (10.0%). The percentage of
all persons with asthma in southeastern Pennsylvania has increased over 40% in the past
decade. In 1991, 5.2% of persons had asthma
compared with 7.4% in 2000.13

PROGRAM DESCRIPTION/METHODS
The Jefferson Health System is an integrated
delivery system comprising several hospital
systems in the tri-state metropolitan Philadelphia region. It includes the Albert Einstein
Health Network, Frankford Healthcare System,
Main Line Health System, Thomas Jefferson
University Hospital, and Magee Rehabilitation
Center and their various affiliates. It serves approximately 26% of the nearly 6 million living
in the region and has approximately 750 PCPs
and over 2,500 specialists in its various system
networks.
The premise of our “preceptor model” focuses on matching a single PCP-learner with a
disease specialist for a half-day session. PCPs
affiliated with the Jefferson Health System
were invited to participate in a continuing education program for asthma management. The
two physicians work together, seeing patients
and discussing primary care “pearls” of asthma
care. In addition to the physician preceptorship, the office staff of each physician-learner
received an in-service session by a professional
asthma nurse practitioner in the use of an
asthma “plan,” metered dose inhaler technique, and proper use of the peak flow meter.
The purpose of this additional feature was to
ensure that patients of the PCP-learners would
receive appropriate asthma education.
Both PCP-learners and preceptors were financially compensated for their time (typically
a $350 honorarium per physician for a half-day
session, distributed by JeffCare, Inc.). The results reviewed include data from asthma
claims (inpatient, outpatient, emergency room)
for the year 1999, which preceded the inter-
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vention program. This was compared with
claims collected post-intervention in the year
2000. Participant PCP-learners were drawn
from the entire Jefferson Health System network of PCPs. Letters of explanation and invitation were faxed on multiple occasions, as well
as “direct detailing” visits by our clinical management and provider relations personnel. In
this initial program recruitment effort, there
were no attempts to preselect participants
based on prior utilization behaviors or cost profiles. PCP-learners were included in this program based on their expressed interest in participating. The JeffCare, Inc., staff facilitated
appointments, and asthma specialists in the
system were matched with interested PCPlearners. Preceptor faculty were instructed to
review the various diagnostic and treatment
guidelines as supported by the National Institutes of Health guidelines for asthma.14
JeffCare, Inc., as a physician hospital organization, has been involved in a full risk-based
insurance product since 1997. The significance
of participation in such a full-risk percentage
of premium arrangement is noteworthy as such
arrangements allow for very reliable captive
claims data by the risk-bearer, in this case Jefferson University Hospital’s managed care division, JeffCare, Inc. JeffCare’s risk arrangement was a full assignment of risk for which
the health system bore total exposure for losses
and catastrophic claims. Many other health systems in the United States have engaged in “partial” or lesser risk arrangements with managed
care partners. Full-risk arrangements, if nothing else, allow the holder of risk a legitimate
access to the claims activity for which they
were involved. This enables a reasonable categorization of data outcomes for this review.
Claims data relating to asthma care were reviewed retrospectively in an attempt to compare utilization data for 2 successive years’
worth of claims. In essence, we were able to
view costs and utilization for a given physician/practice before and after the preceptorship intervention. Data were culled in the aggregate from the JeffCare, Inc., database from
its risk-based population of patients. These patient claims are from patients cared for by our
physician-learners in this project. The prepaid
capitation amounts were not factored into the

cost/utilization evaluation, as there was no
clear way to segregate that portion of capitation that would apply to asthma-related care.
Owing to changes in plan participation, only
the 32 PCP-learners directly affiliated with
JeffCare, Inc., were studied for this analysis.
While we have trained approximately 140 PCPlearners in the entire Jefferson Health System
to date, only PCP-learners for whom we had
risk-based data both pre- and post-learning intervention were included in the summary review in this article. Not every member of the
Jefferson Health System hospital consortium
was actively a part of the risk-based contract at
the start of this intervention, and thus the reliability of pre- and post-intervention data
would not be as firm as the included subset of
PCP-learners used for this analysis. The JeffCare, Inc.-based physicians are spread across
25 capitated offices in southeastern Pennsylvania and southern New Jersey. Data from February 1, 1998 to June 22, 2001 were extracted
from the entire claims database. Claims data for
the 25 capitated offices were extracted from the
larger data set. Only claims that carried a primary diagnosis code for asthma (ICD-9: 493.0,
493.1, 493.9) were included. Claims studied
were for 1 year beginning from the date of the
preceptorship intervention as compared with 1
year’s worth of data prior to the intervention.
Outcomes used were actual paid amounts,
and hospital bed days. These outcomes were
grouped into two categories based on the date
the PCP participated in the education program.
Therefore, each physician is his/her own control. Student’s t test was employed as the test
of significance, with a critical p value of 0.05.
Subgroups were examined based on age, gender, and site of care delivery. Data were compiled using Microsoft Access 97 and were analyzed with SPSS version 7.5.3.0 for Windows
from SPSS, Inc.
RESULTS
Pharmaceutical utilization patterns in study group
While the initial set of data (Table 1) observes
potential impact of the intervention model on
certain utilization categories, Tables 2 and 3
look at potential pharmaceutical prescribing
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TABLE 1. CLAIMS DATA
n

Total
Pre
Post
Males
Pre
Post
Females
Pre
Post
Children (,18 years)
Pre
Post
Adults ($18 years)
Pre
Post
Outpatient/office
Pre
Post
Emergency
Pre
Post
Inpatient
Pre
Post

FOR JEFF CARE, INC .,

Mean paid amount

PCP-LEARNERS

p

Total

Paid bed days1

p

Total

691
931

$160.08
$75.23

0.015

$110,615.28
$70,039.13

0.1158
0.0591

0.04

80.02
55.02

293
356

$105.76
$84.52

0.549

$30,987.68
$30,089.12

0.0819
0.0702

0.762

24.00
24.99

398
575

$200.07
$69.47

0.014

$79,627.86
$39,945.25

0.1407
0.0522

0.023

56.00
30.02

197
399

$74.01
$46.71

0.007

$14,579.97
$18,637.29

0.1066
0.0602

0.02

21.00
24.02

494
532

$194.41
$96.61

0.071

$96,038.54
$51,396.52

0.1194
0.0583

0.113

58.98
31.02

559
787

$42.85
$50.42

0.015

$23,953.15
$39,680.54

57
71

$146.32
$90.32

0.084

$8,340.24
$6,412.72

75
73

$1,044.31
$327.94

0.048

$78,323.25
$23,939.62

1.07
0.75

0.245

80.25
54.75

1 The bed days column represents the mean number of inpatient days per person over the time period. The
total column is the mean 3 n.

impact that might relate to this intervention
model.
In an attempt to evaluate impact on prescribing behaviors as a result of the preceptorship intervention, proprietary pharmaceutical
industry data were accessed representing portions of eastern Pennsylvania, central and
southern New Jersey, and portions of Delaware
(NDC Health Information Services [Arizona],
Inc.). This allowed comparison of the JeffCare,
Inc., participants with regional prescribers who
had not had similar preceptorship experience.
All data for Table 2 used new prescription

TABLE 2.

counts between August 1999 and August 2000.
The categories are defined as follows: asthma
controller segment (Intal® [Fisons], Tilade®
[Fisons], Aerobid ® [Forest], Azmacort®
[Rhone-Poulenc Rorer], Flovent® [Glaxo],
Qvar® [3M Riker], Vanceril® [Schering], Atrovent® Inhalation Aerosol [Boehringer Ingelheim], Combivent® [Boehringer Ingelheim],
Foradil® [Ciba-Geigy], Serevent ® [Glaxo], Accolate® [ICI], Singulair® [Merck & Co.], Zyflo®
[Abbott], Pulmicort® [Astra], Beclovent®
[Glaxo]); total ICS (Aerobid ® [Forest], Azmacort, Flovent, Qvar, Vanceril, Pulmicort, Beclo-

PRESCRIBING PATTERNS

OF

PCP PARTICIPANTS

Eastern Pa NJ DE region

Asthma controller
Total ICS
Asthma relief

JeffCare participants

August
1999

August
2000

%
change

August
1999

August
2000

%
change

259,928
135,594
288,220

292,578
145,385
286,736

13%
7%
21%

1,626
909
2,063

1,948
1,024
1,858

20%
13%
210%

ICS, inhaled corticosteroid.
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TABLE 3.

JEFF CARE LEARNERS COMPARISON

Asthma controller1
ICS
LTM
SABA1

OF

ASTHMA PRESCRIBING HABITS

FOR

1999 VERSUS 2000

AND

2001

August 1999

August 2000

p

August 1999

August 2001

p

31.88
17.82
5.84
40.45

38.20
20.08
8.63
36.43

0.023
0.142
0.007
0.102

31.88
17.82
5.84
40.45

51.39
22.78
11.12
34.33

0.00006
0.04138
0.00844
0.09651

Data are from NDC Health Information Services (Arizona), Inc. LTM, leukotriene agents; SABA, short-acting
beta-agonists.
1 New prescriptions.

vent); and asthma relief (albuterol, Maxair®
[3M Riker], Proventil® [Schering], Ventolin®
[Allen & Hanburys]).
Table 3 looks at the comparison of the JeffCare Learner group against their own prescribing behaviors over 2 years of observation.
Analysis
Table 1 reflects statistically significant support for the observation that total asthma care
costs (outpatient and inpatient) for the sample
of PCP-learners reviewed demonstrates an
overall savings of about $40,500 for the time period studied. In a breakdown analysis by categories including sex, age, as well as location/type of service, findings are consistent
with the fact that participant-learners experienced a change in utilization behaviors following the preceptor experience.
Outpatient care costs increased post-intervention, signaling the likelihood of PCP-learners using a greater amount of outpatient
services secondary to their preceptorship ex-

perience. Yet, inpatient costs for this group
were dramatically reduced by a total of almost
$55,000.
In the review of pharmaceutical use (Table
2), the comparisons against regional use patterns are noteworthy (NDC Health Information
Services [Arizona], Inc.). While the total ICS
utilization for the regional group increased by
7% from 1999 to 2000, the Jefferson group
showed a 13% overall increase post-intervention. Similarly, rescue therapy for the regional
group dropped by 1%, whereas the Jefferson
group showed a 10% drop. These are positive
trends for the intervention group studied, as it
was hoped that these patterns would manifest
after formal preceptor education, and certainly
consistent with the patterns manifested in utilization data in Tables 1 and 2.
Figure 1 (a graphical depiction of data in
Table 3) is a review of the JeffCare, Inc., PCPlearners group comparing prescribing behaviors for the 1999 pre-intervention period with
post-intervention segments for both years 2000
and 2001. Categories include total asthma con-

FIG. 1. JeffCare learners comparison of asthma prescribing habits for 1999 versus 2000 and 2001. *New prescriptions.
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trollers, ICS, LTM, and SABA. This demonstrates a clear improvement in behaviors by the
PCP-learners who participated in the preceptor program in their use and prescribing of
asthma controllers, with an overall decrease in
the use of rescue therapy medications, and an
increase in the use of ICSs.

STUDY CRITICISMS
Unquestionably, the program was first designed solely as an innovative instructional
model to promote improved primary care
asthma intervention by our network of PCPs.
Consideration of a formal patient study model
was not the driving force behind this program.
Nonetheless, care was taken subsequent to program implementation to cull data that were
statistically valid in the comparison areas of interest. However, since the guidelines for preceptors were fairly “open-ended” and subject
to variable interpretation, each PCP-learner
may have had varying emphasis based on the
bias of the preceptor involved. This can be controlled somewhat in future iterations by a more
formalized and regimented structured set of
minimal requirements for items a preceptor
must include in a given session.
In attempting to define “value” to the program by the review of claims-based information, we readily acknowledge the difficulty in
assigning hard savings as compared with the
actual cost of running the program. We used a
reliable “n” of PCP-learners who were in the
full-risk program throughout the preceptor
intervention time frame, and we reported a
savings accordingly based on this number.
Whether this can be extrapolated to the larger
group of learners is pure conjecture. The true
cost of the program to JeffCare, Inc., is small
for no other reason than that we utilized staff
already employed for various other physician
hospital organization functionalities. Additional costs to JeffCare, Inc., would mainly be
administrative time, office-based materials,
phones, and the like. We did not attempt to
configure these costs as part of the program,
but suspect the amounts would not be significant under our particular framework of operations.

An additional question could be raised about
the potential for “spillover” effect on practices
impacted upon by the PCP-learner involvement and his/her staff’s involvement with the
in-service program. This was not a part of the
scope of this particular effort, though worthy
of future consideration in additional studies of
this nature.
A significant program modification in the
preceptorship model begins in early 2003. It
will include the employ of professionally
trained “standardized patients” in which PCPlearners will interview three or four special
case studies in person and then be debriefed by
one of our asthma specialists on campus. This
should provide for a more uniform experience,
easier evaluative feedback from our learners,
and an ability to more efficiently utilize grant
funds to train a larger number of participants.
We also have engaged in a new “partnership” model we call the “Triangular Partnership.” Future preceptor programs will now include not only a Pharma industry partner, but
also a managed care entity. In so doing, we will
have more controlled and timely claims data
analysis capabilities (clearly a constraint in this
study as we were limited to a smaller “n” of
participants for our own captive risk data). We
are currently in the start of one such program
(start date September 2002) and expect to begin a second “Triangular Partnership” in December 2002/January 2003. This additional
“partner” brings significant value to future
studies in terms of the availability of claims
data that will not always be available in such
efforts given the reduction of “risk assumption” models by health care systems in the near
future.
An additional criticism can center on the validity of concluding that there is a “cause and
effect” relationship between the utilization
data and the fact that these participants were
involved in such a program. There may indeed
be other variables responsible for these outcomes that this evaluation cannot take into full
account. Finally, the study does not account for
patient satisfaction or quality of life change preand post-intervention. The study size required
for this analysis was beyond the scope and resource of this effort, but such evaluative tools
are available and well tested.15
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DISCUSSION
The influence of local medical opinion leaders in the approach to innovative models of
learning for PCPs is well demonstrated.16 We
are of the view that combining the preceptorship experience with the nurse practitioner patient-training lessons for office staff offers the
optimal training intervention for our network
PCP-learners. We believe it will help to address
one of the biggest challenges in asthma management, the noncompliant patient.17 In addressing the special needs of our inner city population, where asthma management can be
most challenging, recognition of the fact that
there is significant underuse of ICSs (despite
admonitions from the National Institutes of
Health asthma guidelines) and a greater need
to impact the education of this population further underscores the importance of this approach.18 As noted in the self-critique, a “cause
and effect” impact on propriety of asthma controlling agent prescribing is, at best, inferred.
However, a pattern is suggested that warrants
larger studies with a more direct tie to patient
participation and involvement. If the “Preceptorship” model does lend toward a greater appropriateness of use of ICSs and decreased use
of rescue therapies, then this interactive approach to physician education warrants further
evaluation.19

CONCLUSION
The JeffCare preceptor model offers an innovative and interactive alternative to traditional continuing medical education-based didactic lecture format for continuing education
of PCP-learners. The opportunity for interindustry partnership is an attractive feature of
the model, and physicians favor the informality of the one-to-one interaction with an asthma
specialist. Preliminary claims data, as well as
prescribing patterns in pre- and post-intervention years, suggest a possible relationship between this focused training model and improved utilization and more appropriate
prescribing patterns. Use of the “standardized
patient” model as well as pre- and post-physician-learner surveys for self-assessment of

preparedness for primary asthma care management issues will be necessary in future iterations of this program.
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